ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, the BCR-ABL oncoprotein decreases the adhesion of LSCs to the bone marrow environment through constitutive phosphorylation of several focal adhesion-associated molecules [49].